Cigna executive Neville Everett offloaded 617 shares in a pre-planned transaction, maintaining a remaining direct stake of 5,053 shares valued at $1.45 million.
Insider sale was a small, pre-planned transaction under Rule 10b5-1, indicating no immediate concern.
Neville Everett, Executive Vice President at The Cigna Group, sold 617 shares of common stock on September 3, 2026. The transaction, valued at approximately $175,259, was executed under a pre-arranged Rule 10b5-1 trading plan. Following the sale, the executive retains a direct ownership stake of 5,053 shares in the healthcare giant.
The sale was executed under a Rule 10b5-1 trading plan adopted on June 2, 2026, which removes discretionary timing from the process by establishing a predetermined schedule for equity sales.
No, the sale is considered routine and pre-planned. Cigna maintains strong fundamentals, including 8% year-over-year revenue growth and a forward price-to-earnings multiple of 8.7x.